Related references
Note: Only part of the references are listed.The Comparative Toxicogenomics Database: update 2019
Allan Peter Davis et al.
NUCLEIC ACIDS RESEARCH (2019)
In Silico Prediction of Small Molecule-miRNA Associations Based on the HeteSim Algorithm
Jia Qu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Integrative graph regularized matrix factorization for drug-pathway associations analysis
Ling-Yun Dai et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
2018 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2019)
MicroRNAs and complex diseases: from experimental results to computational models
Xing Chen et al.
BRIEFINGS IN BIOINFORMATICS (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
BNPMDA: Bipartite Network Projection for MiRNA-Disease Association prediction
Xing Chen et al.
BIOINFORMATICS (2018)
Inferring potential small molecule-miRNA association based on triple layer heterogeneous network
Jia Qu et al.
JOURNAL OF CHEMINFORMATICS (2018)
A heterogeneous label propagation approach to explore the potential associations between miRNA and disease
Xing Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
Heter-LP: A heterogeneous label propagation algorithm and its application in drug repositioning
Maryam Lotfi Shahreza et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2017)
RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction
Xing Chen et al.
RNA BIOLOGY (2017)
Identifying drug-pathway association pairs based on L1L2,1-integrative penalized matrix decomposition
Dong-Qin Wang et al.
ONCOTARGET (2017)
PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction
Zhu-Hong You et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Identifying drug-pathway association pairs based on L2,1-integrative penalized matrix decomposition
Jin-Xing Liu et al.
BMC SYSTEMS BIOLOGY (2017)
Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation
Mahban Rahimifard et al.
AGEING RESEARCH REVIEWS (2017)
Implementing Genome-Driven Oncology
David M. Hyman et al.
CELL (2017)
Drug-target interaction prediction: databases, web servers and computational models
Xing Chen et al.
BRIEFINGS IN BIOINFORMATICS (2016)
CancerResource-updated database of cancer-relevant proteins, mutations and interacting drugs
Bjoern-Oliver Gohlke et al.
NUCLEIC ACIDS RESEARCH (2016)
Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information
Hong Yang et al.
NUCLEIC ACIDS RESEARCH (2016)
Efficient Drug-Pathway Association Analysis via Integrative Penalized Matrix Decomposition
Cong Li et al.
IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2016)
NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning
Xing Chen et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Identifying novel associations between small molecules and miRNAs based on integrated molecular networks
Yingli Lv et al.
BIOINFORMATICS (2015)
Prediction of potential disease-associated microRNAs based on random walk
Ping Xuan et al.
BIOINFORMATICS (2015)
An integrated network platform for contextual prioritization of drugs and pathways
Aldo Segura-Cabrera et al.
MOLECULAR BIOSYSTEMS (2015)
Inferring Association between Compound and Pathway with an Improved Ensemble Learning Method
Meiyue Song et al.
MOLECULAR INFORMATICS (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA
Xing Chen
SCIENTIFIC REPORTS (2015)
KATZLDA: KATZ measure for the lncRNA-disease association prediction
Xing Chen
SCIENTIFIC REPORTS (2015)
Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs
Sham Mailankody et al.
JAMA ONCOLOGY (2015)
Exploring the complexity of pathway-drug relationships using latent Dirichlet allocation
Naruernon Pratanwanich et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2014)
Linking Biochemical Pathways and Networks to Adverse Drug Reactions
Huiru Zheng et al.
IEEE TRANSACTIONS ON NANOBIOSCIENCE (2014)
Drug-pathway interaction prediction via multiple feature fusion
Meiyue Song et al.
MOLECULAR BIOSYSTEMS (2014)
Drug target inference through pathway analysis of genomics data
Haisu Ma et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Camille Abboud et al.
BLOOD (2013)
Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway
Antonio Speciale et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Predicting drug-target interaction networks of human diseases based on multiple feature information
Weiming Yu et al.
PHARMACOGENOMICS (2013)
CancerDR: Cancer Drug Resistance Database
Rahul Kumar et al.
SCIENTIFIC REPORTS (2013)
Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action
Shan Zhao et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
iFad: an integrative factor analysis model for drug-pathway association inference
Haisu Ma et al.
BIOINFORMATICS (2012)
FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment
Haisu Ma et al.
BIOINFORMATICS (2012)
Positive-unlabeled learning for disease gene identification
Peng Yang et al.
BIOINFORMATICS (2012)
Drug-target interaction prediction by random walk on the heterogeneous network
Xing Chen et al.
MOLECULAR BIOSYSTEMS (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2012)
Gaussian interaction profile kernels for predicting drug-target interaction
Twan van Laarhoven et al.
BIOINFORMATICS (2011)
Pathway Commons, a web resource for biological pathway data
Ethan G. Cerami et al.
NUCLEIC ACIDS RESEARCH (2011)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Steven M. Paul et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Solving the apparent diversity-accuracy dilemma of recommender systems
Tao Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Supervised prediction of drug-target interactions using bipartite local models
Kevin Bleakley et al.
BIOINFORMATICS (2009)
CellMiner: a relational database and query tool for the NCI-60 cancer cell lines
Uma T. Shankavaram et al.
BMC GENOMICS (2009)
Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.
Charles M. Rudin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
Yoshihiro Yamanishi et al.
BIOINFORMATICS (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Targeting bile-acid signalling for metabolic diseases
Charles Thomas et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Drug target identification using side-effect similarity
Monica Campillos et al.
SCIENCE (2008)
ChemBank: a small-molecule screening and cheminformatics resource database
Kathleen Petri Seiler et al.
NUCLEIC ACIDS RESEARCH (2008)
Factor analysis for gene regulatory networks and transcription factor activity profiles
Iosifina Pournara et al.
BMC BIOINFORMATICS (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Finding new drug targets in the 21st century
MA Lindsay
DRUG DISCOVERY TODAY (2005)
Finding scientific topics
TL Griffiths et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Advances in high content screening for drug discovery
KA Giuliano et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2003)
Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
R Ulrich et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
